Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Naturalistic Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of EGFR TKI in Male Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer of Adeno Histology Failed 1st Line Chemotherapy

NCT00922025 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00922025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00922025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Naturalistic Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of EGFR TKI in Male Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer of Adeno Histology Failed 1st Line Chemotherapy
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
December 31, 2010
Enrollment
186 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer